Form 4: BullFrog AI Director Granted 15,000 Stock Options

BullFrog AI Holdings, Inc. Director R. Don Elsey was granted 15,000 stock options with an exercise price of $1.43, vesting in 2026.

Summary

• R. Don Elsey, a Director of BullFrog AI Holdings, Inc. (BFRG), was granted 15,000 stock options on September 25, 2025.
• The options were issued under the Company's 2022 Equity Compensation Plan, as amended.
• The exercise price for these options is $1.43 per share.
• The options vest on the earlier of September 25, 2026, and the date of the Company's annual meeting for fiscal year 2026.
• Forfeiture restrictions will accelerate upon a change in control of the Company or a significant financing event.
• The stock options expire on September 25, 2035.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a positive signal for aligning interests and retention, but it's a routine compensation event rather than a major strategic announcement. The exercise price of $1.43 provides a clear target for value creation.

Positives

• Granting stock options to a director aligns management and director interests with shareholder value, incentivizing long-term performance.
• The vesting schedule encourages continued commitment and retention of the director.
• Acceleration clauses for change in control or significant financing provide potential upside for the director, which can be a positive incentive.

Negatives

• The issuance of additional stock options introduces potential future dilution for existing shareholders if the options are exercised.
• The value of the options is contingent on the company's stock price appreciating above the $1.43 exercise price.

Risks

• Potential future dilution of existing shareholders if the 15,000 stock options are exercised.
• The value of the options is entirely dependent on the future stock performance of BullFrog AI Holdings, Inc., and there is no guarantee of appreciation.

Future Outlook

The vesting schedule and expiration date of the options indicate a long-term incentive for the director, aligning their future interests with the company's performance through at least September 2026 and potentially until September 2035.

Industry Context

Equity compensation, particularly stock options, is a standard practice in the biotechnology and AI sectors to attract and retain key talent, including directors, and to align their incentives with long-term company growth and shareholder value. This grant is consistent with typical compensation strategies in these industries.

Comparison to Industry Standards

• Granting stock options to directors is a common practice across publicly traded companies, especially in growth-oriented sectors like AI and biotech, to incentivize performance and retention.
• The size of the grant (15,000 options) and the exercise price of $1.43 would need to be compared against similar grants at peer companies of comparable market capitalization and stage of development to assess if it's within industry norms. Without specific peer data, a direct comparison is not possible from this filing alone.

Related Party Transactions

• R. Don Elsey, a Director of BullFrog AI Holdings, Inc., received 15,000 stock options as part of his compensation, which constitutes a transaction between the company and a related party.

Stakeholder Impact

• Shareholders: Potential for future dilution if options are exercised, but also potential for increased long-term value creation due to aligned director incentives.
• Management: R. Don Elsey's incentives are now more closely tied to the company's stock performance, encouraging decisions that enhance shareholder value.

Next Steps

• The options will vest on the earlier of September 25, 2026, or the date of the Company's annual meeting for fiscal year 2026.
• The director may exercise the options at any time after vesting and before the expiration date of September 25, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine equity compensation grant to a director, which is a standard practice to align interests. It does not contain information significant enough to warrant a change in investment recommendation, nor does it provide new fundamental data to alter the company's valuation. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

BullFrog AI Holdings, BFRG, Stock Options, Equity Compensation, Insider Transaction, Director Compensation, SEC Form 4, Ownership Change